Celon Pharma S.A. (CLN.WA)

PLN 23.85

(-7.38%)

Operating Expenses Summary of Celon Pharma S.A.

Celon Pharma S.A.'s latest annual operating expenses in 2023 was 174.34 Million PLN , down -3.15% from previous year.
Celon Pharma S.A.'s latest quarterly operating expenses in 2024 Q2 was 43.26 Million PLN , up 1100.39% from previous quarter.
Celon Pharma S.A. reported a annual operating expenses of 132.74 Million PLN in annual operating expenses 2022, up 12.09% from previous year.
Celon Pharma S.A. reported a annual operating expenses of 118.42 Million PLN in annual operating expenses 2021, up 69.31% from previous year.
Celon Pharma S.A. reported a quarterly operating expenses of 43.26 Million PLN for 2024 Q2, up 1100.39% from previous quarter.
Celon Pharma S.A. reported a quarterly operating expenses of 36.68 Million PLN for 2023 Q3, up 146.14% from previous quarter.

Annual Operating Expenses Chart of Celon Pharma S.A. (2023 - 2012)

Historical Annual Operating Expenses of Celon Pharma S.A. (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	174.34 Million PLN	-3.15%
2022	132.74 Million PLN	12.09%
2021	118.42 Million PLN	69.31%
2020	69.94 Million PLN	-3.75%
2019	72.67 Million PLN	17.72%
2018	61.73 Million PLN	9.01%
2017	56.62 Million PLN	6.06%
2016	53.39 Million PLN	69.88%
2015	31.43 Million PLN	61.28%
2014	19.48 Million PLN	-44.03%
2013	34.82 Million PLN	17.72%
2012	29.58 Million PLN	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	4.6 Million PLN	-86.89%
2024 Q2	43.26 Million PLN	1100.39%
2023 Q3	36.68 Million PLN	146.14%
2023 Q1	36.59 Million PLN	16.76%
2023 FY	128.57 Million PLN	-3.15%
2023 Q2	14.9 Million PLN	-59.27%
2023 Q4	35.09 Million PLN	-4.33%
2022 Q2	34.82 Million PLN	12.11%
2022 Q1	31.06 Million PLN	22.46%
2022 FY	132.74 Million PLN	12.09%
2022 Q4	31.33 Million PLN	-11.84%
2022 Q3	35.54 Million PLN	2.06%
2021 Q3	35.46 Million PLN	17.22%
2021 FY	118.42 Million PLN	69.31%
2021 Q4	25.36 Million PLN	-28.47%
2021 Q1	29.46 Million PLN	97.23%
2021 Q2	30.25 Million PLN	2.68%
2020 Q2	25.55 Million PLN	132.61%
2020 Q1	10.98 Million PLN	-52.01%
2020 Q4	14.93 Million PLN	-30.13%
2020 FY	69.94 Million PLN	-3.75%
2020 Q3	21.37 Million PLN	-16.34%
2019 Q3	17.03 Million PLN	5.78%
2019 Q1	16.64 Million PLN	-13.85%
2019 Q2	16.1 Million PLN	-3.27%
2019 FY	72.67 Million PLN	17.72%
2019 Q4	22.89 Million PLN	34.4%
2018 Q3	14.79 Million PLN	6.44%
2018 Q2	13.9 Million PLN	1.4%
2018 Q1	13.71 Million PLN	-0.47%
2018 Q4	19.32 Million PLN	30.58%
2018 FY	61.73 Million PLN	9.01%
2017 Q4	13.77 Million PLN	6.16%
2017 Q3	12.97 Million PLN	-5.42%
2017 FY	56.62 Million PLN	6.06%
2017 Q2	13.72 Million PLN	-15.08%
2017 Q1	16.15 Million PLN	-54.09%
2016 Q2	14.48 Million PLN	6.43%
2016 FY	53.39 Million PLN	69.88%
2016 Q4	35.19 Million PLN	417.78%
2016 Q1	13.61 Million PLN	-54.77%
2016 Q3	6.79 Million PLN	-53.08%
2015 Q4	30.09 Million PLN	264.44%
2015 FY	31.43 Million PLN	61.28%
2015 Q3	8.25 Million PLN	0.0%
2014 FY	19.48 Million PLN	-44.03%
2013 FY	34.82 Million PLN	17.72%
2012 FY	29.58 Million PLN	0.0%

Peer Operating Expenses Comparison of Celon Pharma S.A.

Name	Operating Expenses	Operating Expenses Difference